Related Experiment Videos
Rapid recurrence of membranous nephropathy in a related allograft
Abstract:
A patient with membranous nephropathy (MN) received a renal allograft from his brother. The allograft functioned immediately but nephrotic range proteinuria developed seven days after transplantation in the absence of any signs of rejection. Renal function deteriorated five weeks after transplantation due to ureteric obstruction. Nephrostomy drainage resulted in the return of renal function to normal and demonstrated that the allograft was the source of the nephrotic range proteinuria. An open renal biopsy of the allograft performed at the same time revealed the presence of recurrent MN. The recipient was investigated in an attempt to identify possible humoral immune mechanisms that may explain this very rapid recurrence of MN.
Insights
Membranous nephropathy (MN) recurred rapidly in a kidney transplant recipient. This case highlights the potential for swift recurrence of this glomerular disease in allografts.
Area of Science:
- Nephrology
- Immunology
- Transplantation
Background:
- Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults.
- Kidney transplantation is a treatment option for end-stage renal disease (ESRD) caused by MN.
- Recurrence of MN in the allograft can lead to graft dysfunction.
Observation:
- A patient with MN received a kidney allograft which functioned initially.
- Nephrotic-range proteinuria developed seven days post-transplant without rejection signs.
- Ureteric obstruction caused renal function deterioration, which improved with nephrostomy drainage.
Findings:
- Renal biopsy confirmed recurrent membranous nephropathy in the allograft.
- The allograft was identified as the source of proteinuria.
- Investigations explored humoral immune mechanisms for rapid recurrence.
Implications:
- This case underscores the possibility of very rapid MN recurrence post-kidney transplantation.
- Understanding the immune mechanisms is crucial for preventing or managing recurrent MN.
- Further research into humoral factors may improve long-term allograft survival in MN patients.